Clinical Trials
18 trialsNCT04248582 2026-04-15
Cryotherapy for Locally Advanced Esophageal Cancer
Hunter Holmes Mcguire Veteran Affairs Medical Center
Phase 1 Active not recruiting
NCT07218367 2026-02-13
Phase I Trial of pH Resections of GBM at VA
VA Office of Research and Development
Phase 1 Not yet recruiting
NCT05519241 2025-09-02
A Phase I Intravesical PPM Therapy for NMIBC
VA Office of Research and Development
Phase 1 Recruiting
NCT05430009 2022-08-01
Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer
VA Ann Arbor Healthcare System
Phase 1 Recruiting
NCT00841399 2020-03-31
Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients
Walter Reed Army Medical Center
Phase 1 Completed
NCT00854789 2020-03-31
Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer
Walter Reed Army Medical Center
Phase 1 Completed
NCT02019524 2020-03-18
J65
San Antonio Military Medical Center
Phase 1 Completed
NCT02653612 2018-03-02
Intraoperative Imaging of Pulmonary Adenocarcinoma
VA Office of Research and Development
Phase 1 Withdrawn
NCT01574222 2018-01-18
VTNSCLC
VA Office of Research and Development
Phase 1 Terminated
NCT01047761 2016-11-01
Exercise for Stable Myasthenia Gravis
Baltimore VA Medical Center
Phase 1 Unknown
NCT02115919 2016-08-19
Safety Study of Multikine in the Treatment of Perianal Warts
United States Naval Medical Center, San Diego
Phase 1 Terminated
NCT00028418 2015-03-25
Clofarabine in Chronic Lymphocytic Leukemia
FDA Office of Orphan Products Development
Phase 1 Completed
NCT00029900 2015-03-25
ADI-PEG in Patients With Metastatic Melanoma
FDA Office of Orphan Products Development
Phase 1 Completed
NCT00030043 2015-03-25
An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors
FDA Office of Orphan Products Development
Phase 1 Completed
NCT00108186 2014-10-29
Celecoxib Treatment for Lung Cancer
VA Office of Research and Development
Phase 1 Withdrawn
NCT00164658 2010-01-07
Evaluating Tools for Health Promotion and Disease Prevention
Centers for Disease Control and Prevention
Phase 1 Completed
NCT00108264 2009-01-21
Tumor RNA Transfected Dendritic Cell Vaccines
VA Office of Research and Development
Phase 1 Completed
NCT00216437 2007-11-12
Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma
James A. Haley Veterans Administration Hospital
Phase 1 Terminated